Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-23 Purchase | 2024-10-24 08:30 am | Aprea Therapeutics Inc. | APRE | Gilad Oren President/CEO | 500 | $3.915 | $1,958 | 335,195 (Indirect Direct) | View |
| 2024-10-15 Purchase | 2024-10-16 08:31 am | Aprea Therapeutics Inc. | APRE | Gilad Oren President/CEO | 250 | $2.9 | $725 | 334,695 (Indirect Direct) | View |
| 2024-10-10 Purchase | 2024-10-15 08:31 am | Aprea Therapeutics Inc. | APRE | Gilad Oren President/CEO | 1,150 | $2.5835 | $2,971 | 334,445 (Indirect Direct) | View |
| 2024-03-13 Purchase | 2024-03-14 8:51 pm | Aprea Therapeutics Inc. | APRE | Gilad Oren President, CEO | 2,000 | $7.29 | $14,580 | 326,770 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-28 Option Award | 2024-03-28 5:57 pm | N/A 2024-03-28 | Aprea Therapeutics Inc. | APRE | Gilad Oren President, CEO | 33,625 | $0 | 360,195 (Direct) | View |
| 2022-08-23 Conversion | 2023-03-13 6:30 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Gilad Oren President, CEO | 6,649,610 | $0 | 338,770 (Direct) | View |
| 2023-03-09 Option Award | 2023-03-13 6:30 pm | N/A 2033-03-09 | Aprea Therapeutics Inc. | APRE | Gilad Oren President, CEO | 20,000 | $0 | 338,770 (Direct) | View |
| 2022-07-28 Option Award | 2022-08-01 5:01 pm | N/A 2032-07-28 | Aprea Therapeutics Inc. | APRE | Gilad Oren President, CEO | 250,000 | $0 | 479,014 (Direct) | View |
Ownership | 2022-05-26 4:15 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Gilad Oren President | 0 | $0 | 884,678 (Direct) | View |